7th Medicon Valley Inhalation Symposium

Future Opportunities of Inhalation – Final Program.

When: 3rd–4th October 2018, 08.30–17.30, 09.00–13.00
Where: Medicon Village, Lund, Sweden

All presentations are in English.

Day 1 – Wednesday the 3rd of October 2018

08.30–09.00  Registration Symposium
09.00–09.15  Welcome to MVICs Symposium, MSc Lars Asking, MVIC

New Drugs and Clinical

Chairman: MD Lars-Göran Carlsson

09.15–09.35  Future Opportunities for Inhaled BiomoleculesDr Gunilla Petersson, AstraZeneca
09.35–09.55  Inhaled OxytocinePeter Lambert, Monash University
09.55–10.15  Experiences and Learnings from Pharmacokinetic Studies with Easyhaler Products, Satu Lähelmä, Orion Pharma

10.15–11.10  Coffee and Mingle

Formulation Development

Chairman: Dr Jessica Elversson

11.10–11.30  Parameters Influencing the Performance of Interactive Blends for InhalationNancy Rhein, Christian-Albrechts-Universität, Kiel
11.30-11.50  Lactose for Inhalation: More than a CarrierDr Mohit Mehta, DFE Pharma
11.50–12.10  Development of Nasal ProductsDr René Bommer, PharmAccel

12.10–13.45  Lunch and Mingle


Chairman: Dr Orest Lastow

13.45–14.10  Innovation Challenges in Inhalation Device DevelopmentCharlotte Harris, Team Consulting
14.10–14.35  Cipla’s Broad Respiratory Product Portfolio: Historical and Scientific Aspects, Dr Gur Jai Pal Singh, Cipla
14.35–15.00  Design of a Dual Inhaler System for Lung Delivery of API and Buccal Delivery of ExcipientsWilbur de Kruijf, Medspray BV

15.00–16.00  Coffee and Mingle


Chairman: Dr Per Bäckman

16.00–16.25  Developing Alternative In Vitro Approaches for Bioequivalence Testing of Orally Inhaled Drug Products, Professor Robert Price, University of Bath
16.25–16.50  Do We Understand Absorptive Clearance of Inhaled Drugs in Lung?Professor Ben Forbes, King’s College London
16.50–17.15  Applications of Computer Based Modelling in Support of OIP DesignDr Helena Thörn, AstraZeneca

17.25–17.30  Close and Summary Day 1, MSc Lars Asking, MVIC

17.45–18.30  Drink Reception

18.30  Conference Dinner

Day 2 – Thursday the 4th of October 2018

Tox and Pre-Clinical

Chairman: Dr Karin Svens

09.00–09.25  Toxicology – Practical Considerations for Non-clinical TestingDr Simon Moore, Envigo
09.25–09.50  Predictive Respiratory Toxicology with the GARD In-Vitro Testing Platform, Dr Henrik Johansson, SenzaGen AB
09.50–10.15  Evaluation of Genotoxicity of Impurities, Leachables and Extractables – ISO10993 Meets ICHM7, Dr Stefan Czene, Toxicology Knowledge Team Sweden, TKT

10.15–11.00  Coffee and Mingle

New Opportunities and Regulatory

Chairman: Dr Ingrid Lamberg

11.00–11.25  New Opportunity – 1nhalerDon Smith, 1nhaler
11.25–11.50  Regulatory Aspects of Establishment of Therapeutic Equivalence with Focus on Pharmacodynamic StudiesDr Karolina Thörneke, Swedish MPA
11.50–12.10  Missing Approvals for Abridge Products in EU+US: Why the Bottleneck is Not RegulatoryDr Anders FuglsangFuglsang Pharma

12.10–12.20  Closing Symposium, MSc Lars Asking, MVIC

12.20–13.00  Lunch and Mingle